Introducing the new AltIndexLearn more
Lexicon Pharmaceuticals

Lexicon Pharmaceuticals (LXRX) Earnings Prediction

Updated August 11, 2026 · AltIndex alt-data view going into the print

AltIndex AI Score on Lexicon Pharmaceuticals is 37 — signals lean bearish heading into the print. Underlying trend: 2 of 6 tracked signals trending down over the last 3 months.

Next report
Wednesday, November 4, 2026
EPS Estimate
$-0.07
AltIndex AI Score
37
AI Prediction
Signals bearish into print

LXRX stock price — last 3 months

Lexicon Pharmaceuticals (LXRX) is trading at $2.43, down 0.4% over the last 3 months (from $2.44 three months ago).

What the alt-data signals say about Lexicon Pharmaceuticals right now

Trends across the last 3 months — the run-up to Lexicon Pharmaceuticals’s next earnings print.

Signal Current 3-month change
Job postings 4 ↓ -20.0%
LinkedIn headcount 281 → -1.1%
Sentiment 80% Bullish → flat
Web traffic 6,595 ↓ -14.1%
Employee business outlook 23% Negative → flat
X followers 643 → -0.2%

Full daily-resolution trend charts on every signal are on the LXRX ticker page.

Get alerted when LXRX signals inflect

AltIndex stock alerts fire when alt-data on LXRX breaks out — web traffic spike, hiring surge, sentiment shift — often days before the earnings number confirms it.

Sign up to AltIndex →

Lexicon Pharmaceuticals earnings: frequently asked questions

When does Lexicon Pharmaceuticals report earnings next?
Lexicon Pharmaceuticals (LXRX) is scheduled to report next earnings on Wednesday, November 4, 2026. The exact pre-market or post-market time is set by the company a few days ahead; see the official investor-relations page for confirmation.
What does the AltIndex AI Score say about Lexicon Pharmaceuticals going into earnings?
Current AI Score on Lexicon Pharmaceuticals: 37 — Signals bearish into print. The AI Score combines 10,000+ alternative-data and financial signals into one 0–100 number; higher = signals lean bullish, lower = signals lean bearish. Full per-signal breakdown is on the LXRX ticker page.
What is the EPS estimate for Lexicon Pharmaceuticals?
Analyst consensus EPS estimate for Lexicon Pharmaceuticals’s next quarter: $-0.07. We refresh this from analyst-estimate data daily.
How accurate are AltIndex’s earnings predictions for Lexicon Pharmaceuticals?
AltIndex doesn’t predict the exact EPS number — the alt-data signals don’t see the financials. What the signals can do is tell you whether the underlying business momentum (web traffic, hiring, social audience, sentiment) supports the analyst consensus or contradicts it. AltIndex publishes the full pick history at altindex.com/results — including the misses — so you can verify how the signal-driven calls have performed.
Where can I see the full signal breakdown on Lexicon Pharmaceuticals?
Visit https://altindex.com/ticker/lxrx for the complete per-signal view: AI Score history, web traffic trend chart, 8-platform social audience tracking, hiring activity, news mention volume, sentiment scoring, insider trades and Congressional disclosures.
How can I get alerted before Lexicon Pharmaceuticals reports earnings?
AltIndex stock alerts fire when alt-data signals on a stock break out of their historical range — often days or weeks before the earnings number confirms it. Add LXRX to your watchlist and you’ll get notified when its signals shift. See altindex.com/stock-alerts for the full alert categories.

See every alt-data signal on LXRX

Sign up to see the full daily-resolution trend charts on every signal AltIndex tracks for Lexicon Pharmaceuticals — web traffic, hiring, 8-platform social audience, sentiment, insider trades and the full AI Score breakdown.

Sign up to AltIndex → Log in